International SCN8A Alliance Partners w/ Children's Hospital Colorado to Expand Multidisciplinary Care for SCN8A

April 08, 2025 08:00 PM AEST | By EIN Presswire
 International SCN8A Alliance Partners w/ Children's Hospital Colorado to Expand Multidisciplinary Care for SCN8A
Image source: EIN Presswire
DENVER, CO, UNITED STATES, April 8, 2025 /EINPresswire.com/ -- The International SCN8A Alliance is thrilled to announce a collaboration with Children’s Hospital Colorado Neurogenetics Clinic to enhance care for individuals living with SCN8A-related disorders. This partnership will expand access to expert multidisciplinary care, providing families with a dedicated clinical team that understands the complexities of SCN8A-related disorders, which often include intractable seizures, movement disorders, autism, and a range of other neurological and physical challenges.

The clinic, led by Megan Abbott, MD, at the hospital’s state-of-the-art Multidisciplinary Clinic (MDC) on Anschutz Medical Campus, offers a model of care designed to address the unique needs of patients with rare genetic disorders. The MDC is the largest of its kind, featuring 26 exam rooms, advanced telemedicine capabilities, and a patient-centered design that fosters both clinical excellence and family comfort.

“We are thrilled to partner with Children’s Hospital Colorado to ensure that SCN8A families have access to the highest level of expert, coordinated care,” said Gabi Conecker, Executive Director of the International SCN8A Alliance. “It is powerful to also be partnering with the FamilieSCN2A Foundation to ensure that our families, who share many features and often struggle to find doctors that understand our conditions, have access to informed, specialized care. By bringing together experts in neurology, genetics, and other key specialties, we are providing a crucial resource for families navigating these challenging disorders.”

Collaboration Driving Innovation in Rare Disease Care

This initiative marks an important step forward in the effort to improve treatment and accelerate research for SCN8A-related disorders. The partnership between the International SCN8A Alliance, FamilieSCN2A Foundation, and Children’s Hospital Colorado represents a unique model of cross-disorder collaboration, recognizing the overlapping challenges faced by families impacted by SCN-related disorders.

Leah Myers, Executive Director of the FamilieSCN2A Foundation, the largest global advocacy organization for SCN2A-related disorders, expressed the foundation's enthusiasm for this expansion. "When your child has a rare disease like SRD, parents often have to become experts because most doctors have never even heard of it. That’s why having access to specialized care is so meaningful to our community. Knowing that Dr. Abbott will oversee the care of our SCN2A Warriors brings immense peace of mind—because every decision, every treatment, and every moment matters. There’s no room for guesswork when a life depends on truly understanding the complexities of this condition.” said Myers.

A Comprehensive Approach to SCN8A Care

Families visiting the MDC at Children’s Hospital Colorado will benefit from a streamlined approach to care, reducing the burden of navigating multiple appointments across different specialties. The clinic provides:

• Specialized neurological care, including precision treatment plans for epilepsy, movement disorders, and neurodevelopmental challenges.
• Genetic counseling to help families understand their child’s diagnosis and available treatment options.
• Access to multidisciplinary specialists, including epilepsy experts, developmental pediatricians, physiotherapists, and more.
• A family-centered environment, featuring large exam rooms, a cozy lounge, and custom-designed play areas to create a welcoming space for children and families.

Dr. Megan Abbott, who leads the initiative, emphasized the clinic’s dual focus on clinical excellence and research advancement. "Today marks a significant milestone as we open the doors to our new multidisciplinary clinic dedicated to supporting individuals with SCN2A and SCN8A-related disorders. Our mission is to provide specialized care, advanced treatment options, and compassionate support for families navigating these rare genetic conditions. I am thrilled to start this clinic and give patients and families the personalized care they truly deserve!"

Looking Ahead: Expanding Access to Rare Disease Care
The International SCN8A Alliance remains committed to expanding clinical resources and research opportunities for families affected by SCN8A-related disorders. Through ongoing collaboration with leading hospitals and advocacy organizations, the Alliance continues to drive progress toward better treatments and, ultimately, a cure.

To learn more about the International SCN8A Alliance and its efforts to support families, visit www.scn8aalliance.org.

International SCN8A Alliance
International SCN8A Alliance
+1 202-599-0444
email us here
Visit us on social media:
Facebook
X
LinkedIn
Instagram
YouTube
Other

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.